Bill > HR4846

This bill aims to provide oversight of pharmacy benefit manager (PBM) services. The key provisions are: 1. It requires group health plans or PBMs acting on their behalf to submit annual reports to plan sponsors detailing information on drug costs, rebates, and other PBM financial arrangements. This includes data on individual drugs, therapeutic categories, overall spending, and rebates/fees received from manufacturers. 2. It prohibits contracts between plans/PBMs and drug companies that limit the disclosure of information required in the annual reports. 3. It establishes enforcement mechanisms, including civil monetary penalties for failing to provide timely information or providing false information. 4. It directs the Government Accountability Office to study pharmacy networks, network pricing arrangements, and the use of pharmacies owned by plans or PBMs. The goal of the bill is to increase transparency around PBM practices and the costs of prescription drugs in order to help lower drug prices for consumers. The reporting requirements and oversight aim to shed light on the complex financial relationships between PBMs, drug companies, and health plans.